Literature DB >> 8120563

Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy.

J R Crossen1, D Garwood, E Glatstein, E A Neuwelt.   

Abstract

PURPOSE: To examine behavioral dimensions of treatment outcomes for patients receiving cranial irradiation. Radiation encephalopathy is one of these and refers to significant cognitive and emotional dysfunction following radiation therapy to the brain. Issues of definition, estimated incidence, pathophysiologic mechanisms, and recommended research designs are reviewed in relationship to functional neurobehavioral outcomes. PATIENTS AND METHODS: Twenty-nine studies of adults receiving therapeutic cranial irradiation (TCI) involving 748 patients and 18 studies of prophylactic cranial irradiation (PCI) involving 368 patients are reviewed. Assessment of patient outcomes are summarized for research published since 1980, with specific attention to adverse changes in cognitive and emotional functioning.
RESULTS: Analyses revealed that 213 TCI patients and 100 PCI patients showed encephalopathy attributed to radiation. Manifestations of the late delayed effects of radiotherapy on brain function are related to patient age, total dose of irradiation, fraction sizes, and timing of chemotherapy. Radiation encephalopathy appears to be more common than the pathologic tissue injury of radiation necrosis. Accurate diagnosis of these neurobehavioral sequelae can require follow-up over a period of years with sensitive assessment procedures.
CONCLUSIONS: It is likely that the true incidence of treatment-related side effects of cranial irradiation in adults who survive more than 6 months without brain tumor growth or recurrence has been significantly underestimated. Research designs that include formal neuropsychologic assessment in conjunction with other neurodiagnostic tests can provide more comprehensive evaluation of long-term neurobehavioral outcomes.

Entities:  

Mesh:

Year:  1994        PMID: 8120563     DOI: 10.1200/JCO.1994.12.3.627

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  182 in total

1.  Dementia following treatment of brain tumors with radiotherapy administered alone or in combination with nitrosourea-based chemotherapy: a clinical and pathological study.

Authors:  M C Vigliani; C Duyckaerts; J J Hauw; M Poisson; H Magdelenat; J Y Delattre
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  Phase II study of Ginkgo biloba in irradiated brain tumor patients: effect on cognitive function, quality of life, and mood.

Authors:  Albert Attia; Stephen R Rapp; L Doug Case; Ralph D'Agostino; Glenn Lesser; Michelle Naughton; Kevin McMullen; Robin Rosdhal; Edward G Shaw
Journal:  J Neurooncol       Date:  2012-06-15       Impact factor: 4.130

3.  Chronic administration of the angiotensin-converting enzyme inhibitor, ramipril, prevents fractionated whole-brain irradiation-induced perirhinal cortex-dependent cognitive impairment.

Authors:  Tammy C Lee; Dana Greene-Schloesser; Valerie Payne; Debra I Diz; Fang-Chi Hsu; Mitra Kooshki; Rashida Mustafa; David R Riddle; Weiling Zhao; Michael D Chan; Mike E Robbins
Journal:  Radiat Res       Date:  2012-06-12       Impact factor: 2.841

4.  Case files of the New York City poison control center: paradichlorobenzene-induced leukoencephalopathy.

Authors:  Stephanie H Hernandez; Sage W Wiener; Silas W Smith
Journal:  J Med Toxicol       Date:  2010-06

Review 5.  Renin-angiotensin system blockers and modulation of radiation-induced brain injury.

Authors:  M E Robbins; W Zhao; M A Garcia-Espinosa; D I Diz
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

Review 6.  Radiation Toxicity in the Central Nervous System: Mechanisms and Strategies for Injury Reduction.

Authors:  DeeDee Smart
Journal:  Semin Radiat Oncol       Date:  2017-10       Impact factor: 5.934

7.  Molecular pathways: radiation-induced cognitive impairment.

Authors:  Dana Greene-Schloesser; Elizabeth Moore; Mike E Robbins
Journal:  Clin Cancer Res       Date:  2013-02-06       Impact factor: 12.531

Review 8.  Malignant germ cell tumors metastatic to the brain: a model for a curable neoplasm? The Freiburg experience and a review of the literature.

Authors:  Johannes Lutterbach; Uwe Spetzger; Susanne Bartelt; Axel Pagenstecher
Journal:  J Neurooncol       Date:  2002-06       Impact factor: 4.130

Review 9.  Radiation-induced cognitive impairment--from bench to bedside.

Authors:  Dana Greene-Schloesser; Mike E Robbins
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

Review 10.  Neurocognitive functioning in adult WHO grade II gliomas: impact of old and new treatment modalities.

Authors:  Martin Klein
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.